EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial

Mei Zhang iD, Yibing Lu, Hongwei Ling, Wen Hu, Xuqin Zheng, Mei Huang, Meng Zhao, Xiaoqing Wang, Guanqun Zhang, Yanan Zhang, Tao Yang

Journal of Diabetes Science and Technology · 12.06.2026

DOI: 10.1177/19322968261445103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 12.06.2026. Verfasst von Mei Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, P.R. China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluated the performance and safety of a 15-day real-time continuous glucose monitoring (rtCGM) system in Chinese adults with diabetes, focusing on its accuracy and clinical utility for long-term glucose management.

Methods

A clinical evaluation was conducted using four rtCGM sensors per participant, with placement sites on both the upper arm and the abdomen. The system’s accuracy was assessed using a factory-calibrated model. Primary outcomes included the mean absolute relative difference (MARD), the 20/20% agreement rate, and the proportions of Clarke and Consensus Error Grid in zones A+B.

Results

A total of 74 participants were screened. The MARD values were 8.44% for the upper arm and 8.91% for the abdomen under factory-calibrated model. The 20/20% agreement rates were 95.78% for the upper arm and 94.41% for the abdomen under factory-calibrated model. The Clarke and Consensus Error Grid A+B proportions were 99.53% and 99.96% for the upper arm, and 99.46% and 99.82% for the abdomen under factory-calibrated model, respectively.

Conclusion

The CGM system showed high accuracy, robust alert performance, stable repeatability, and favorable safety over 15 days in Chinese adults with diabetes, supporting its clinical utility for glucose monitoring in these adult patients.

Schlagwörter

Stichwörter der Autor:innen

continuous glucose monitoringdiabetes

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, P.R. China.
  • Department of Endocrinology, The Second Affiliated Hospital of Nanjing Medical University, P.R. China.
  • Department of Endocrinology, The Affiliated Hospital of Xuzhou Medical University, P.R. China.
  • Department of Endocrinology and Metabolism, Huai'an Hospital Affiliated to Xuzhou Medical University and Huai'an Second People's Hospital, P.R. China.
  • Jiangsu Yuwell POCTech Biotechnology Co., Ltd., Danyang, P.R. China.

ORCID-Profile: Mei Zhang

Zitieren

APA

Zhang, M., Lu, Y., Ling, H., Hu, W., Zheng, X., Huang, M., Zhao, M., Wang, X., Zhang, G., Zhang, Y., & Yang, T. (2026). Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968261445103

Vancouver

Zhang M, Lu Y, Ling H, Hu W, Zheng X, Huang M, et al. Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial. Journal of Diabetes Science and Technology. 2026. doi:10.1177/19322968261445103

BibTeX
@article{Zhang2026,
  author = {Zhang, Mei and Lu, Yibing and Ling, Hongwei and Hu, Wen and Zheng, Xuqin and Huang, Mei and Zhao, Meng and Wang, Xiaoqing and Zhang, Guanqun and Zhang, Yanan and Yang, Tao},
  title = {Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  doi = {10.1177/19322968261445103}
}
Kostenlos starten →